1Janson J,Laedtke T,Parisi JE,et al.Increased risk of type 2 diabetes in Alzheimer disease(J).Diabetes,2004;53:474-81.
2Ott A,Stolk RP,van Harskamp F,et al.Diabetes mellitus and the risk of dementia:the Rotterdam Study(J).Neurology,1999;53:1937-42.
3Ronnemaa E,Zethelius B,Sundelof J,et al.Impaired insulin secretion in-creases the risk of Alzheimer disease(J).Neurology,2008;71(14):1065-71.
4Steen E,Terry BM,Rivera EJ,et al.Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's dis-ease-is this type 3 diabetes(J).J Alzheimers Dis,2005;7:63-80.
5Adlerz L,Holback S,Multhaup G,et al.IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling path-ways(J).J Biol Chem,2007;282(14):10203-9.
6Velliquette RA,O'Connor T,Vassar R.Energy inhibition elevatesβ-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice:possible early events in Alzheimer's disease pathogenesis(J).J Neurosci,2005;25(47):10874-83.
7Deane R,Zlokovic BV.Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease(J).Curr Alzheimer Res,2007;4(2):191-7.
9Eckman EA,Eckman CB.Abeta-degrading enzymes:modulators of Alzhe-imer's disease pathogenesis and targets for therapeutic intervention(J).Biochem Soc Trans,2005;33(5):1101-5.
10Iwata N,Tsubuki S,Takaki Y,et al.Metabolic regulation of brain Abetaby neprilysin(J).Science,2001;292(5521):1550-2.
